BAJAJ BROKING

Notification close image
No new Notification messages
card image
Smartworks Coworking Spaces IPO is Open!
Apply for the Smartworks Coworking Spaces IPO through UPI in just minutes.
delete image
card image
Start your SIP with just ₹100
Choose from 4,000+ Mutual Funds on Bajaj Broking
delete image
card image
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
delete image
card image
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
delete image
card image
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
delete image

757658

524743

FISCHER

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

FISCHER MEDICAL VENTURES LIMIT performance

Today’s low

Today’s high

₹ 782.55 ₹ 859.00
₹ 845.05

52 week low

52 week high

₹ 770.10 ₹ 859.00
₹ 845.05

Open Price

₹ 804.00

Prev. Close

₹ 775.85

Volume (Shares)

105711.00

Total traded value

₹ 893.31

Upper Circuit

₹ 931.00

Lower Circuit

₹ 620.70

info

FISCHER MEDICAL VENTURES LIMIT Share Price Update

As of the latest trading session, FISCHER MEDICAL VENTURES LIMIT share price is currently at ₹ 845.05, which is up by ₹ 69.20 from its previous closing. Today, the stock has fluctuated between ₹ 782.55 and ₹ 859.00. Over the past year, FISCHER MEDICAL VENTURES LIMIT has achieved a return of 0.00 %. In the last month alone, the return has been 0.00 %. Read More...

Investment Returns

Over 1 Month 0.00% Over 3 Months 0.00% Over 6 Months 0.00% Over 1 Year 0.00%
demotext Smart Investing Starts here ! Trade Smart with Fast Execution & Zero Account Opening Fees Invest Now

FISCHER MEDICAL VENTURES LIMIT fundamentals


  • Market cap (Cr)

    5,480.30

  • P/E Ratio (TTM)

    8,430.50

  • Beta

    -64.76

  • Book Value / share

    47.63

  • Return on equity

    1.01%

  • EPS (TTM)

    0.10

  • Dividend yield

    0.01%

  • Net profit/quarter (Cr)

    -0.89

info icon alternate text
  • Market cap (Cr)

    5,467.30

  • P/E Ratio (TTM)

    8,430.50

  • Beta

    0.33

  • Book Value / share

    47.63

  • Return on equity

    1.01%

  • EPS (TTM)

    0.10

  • Dividend yield

    0.01%

  • Net profit/quarter (Cr)

    -0.89

info icon alternate text

FISCHER MEDICAL VENTURES LIMIT Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars MAR 2025 (Values in Cr)
Revenue 5.22
Operating Expense 7.00
Net Profit -0.89
Net Profit Margin (%) -17.04
Earnings Per Share (EPS) -0.06
EBITDA -0.90
Effective Tax Rate (%) 21.23
Particulars DEC 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.25
Net Profit 0.20
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.04
EBITDA 0.66
Effective Tax Rate (%) 67.74
Particulars SEP 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.36
Net Profit 0.51
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.10
EBITDA 0.46
Effective Tax Rate (%) -10.86
Particulars JUN 2024 (Values in Cr)
Revenue 0.00
Operating Expense 0.11
Net Profit 0.84
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) 0.16
EBITDA 1.01
Effective Tax Rate (%) 16.83
Particulars MAR 2024 (Values in Cr)
Revenue 11.34
Operating Expense 11.44
Net Profit 0.60
Net Profit Margin (%) 5.29
Earnings Per Share (EPS) 0.11
EBITDA 0.63
Effective Tax Rate (%) 4.76
Particulars MAR 2025 (Values in Cr)
Revenue 5.22
Operating Expense 7.71
Net Profit 0.66
Net Profit Margin (%) 12.64
Earnings Per Share (EPS) 0.05
EBITDA 1.21
Effective Tax Rate (%) 31.25
Particulars MAR 2024 (Values in Cr)
Revenue 11.53
Operating Expense 11.74
Net Profit 0.40
Net Profit Margin (%) 3.46
Earnings Per Share (EPS) 0.36
EBITDA 0.56
Effective Tax Rate (%) 25.92
Particulars MAR 2023 (Values in Cr)
Revenue 0.18
Operating Expense 0.18
Net Profit -0.04
Net Profit Margin (%) -22.22
Earnings Per Share (EPS) -2.12
EBITDA 0.05
Effective Tax Rate (%) 0.00
Particulars MAR 2022 (Values in Cr)
Revenue 0.00
Operating Expense 0.20
Net Profit -0.23
Net Profit Margin (%) 0.00
Earnings Per Share (EPS) -13.52
EBITDA -0.12
Effective Tax Rate (%) -20.00
Particulars MAR 2021 (Values in Cr)
Revenue 0.17
Operating Expense 0.19
Net Profit 0.14
Net Profit Margin (%) 82.35
Earnings Per Share (EPS) 8.18
EBITDA -0.02
Effective Tax Rate (%) 450.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 15.00
ROE % 4.55
ROCE % 5.25
Total Debt to Total Equity 0.03
EBITDA Margin 11.25
Particulars MAR 2023 (Values in Cr)
Book Value / Share -15.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 11.11
Particulars MAR 2024 (Values in Cr)
Book Value / Share 14.73
ROE % 1.01
ROCE % 1.40
Total Debt to Total Equity 0.01
EBITDA Margin 4.86
Particulars MAR 2023 (Values in Cr)
Book Value / Share -15.47
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 11.11
Particulars MAR 2022 (Values in Cr)
Book Value / Share -13.34
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2021 (Values in Cr)
Book Value / Share 0.18
ROE % 155.56
ROCE % -6.35
Total Debt to Total Equity 0.00
EBITDA Margin -11.76
Particulars MAR 2020 (Values in Cr)
Book Value / Share -7.99
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin -11.11
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 37.94
Total Assets 86.32
Total Liabilities 86.32
Total Equity 81.11
Share Outstanding 53500000
Price to Book Ratio 42.41
Return on Assets (%) 2.12
Return on Capital (%) 2.27
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 0.35
Total Liabilities 0.35
Total Equity -0.26
Share Outstanding 172000
Price to Book Ratio -5.43
Return on Assets (%) -10.32
Return on Capital (%) -11.94
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 91.83
Total Liabilities 91.83
Total Equity 79.67
Share Outstanding 53500000
Price to Book Ratio 42.41
Return on Assets (%) 0.43
Return on Capital (%) 0.51
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.03
Total Assets 0.35
Total Liabilities 0.35
Total Equity -0.26
Share Outstanding 172000
Price to Book Ratio -5.43
Return on Assets (%) -10.32
Return on Capital (%) -11.94
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 0.01
Total Assets 0.19
Total Liabilities 0.19
Total Equity -0.22
Share Outstanding 172000
Price to Book Ratio -5.85
Return on Assets (%) -122.22
Return on Capital (%) -145.65
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.04
Total Assets 0.25
Total Liabilities 0.25
Total Equity 0.00
Share Outstanding 172000
Price to Book Ratio 141.67
Return on Assets (%) 55.44
Return on Capital (%) 59.6
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 0.10
Total Assets 0.13
Total Liabilities 0.13
Total Equity -0.13
Share Outstanding 172000
Price to Book Ratio -6.21
Return on Assets (%) -29.75
Return on Capital (%) -52.13
Particulars MAR 2024 (Values in Cr)
Net Income 2.11
Cash from Operations -7.53
Cash from Investing -31.20
Cash from Financing 37.10
Net change in Cash -1.68
Free Cash Flow -7.23
Particulars MAR 2024 (Values in Cr)
Net Income 0.53
Cash from Operations 0.12
Cash from Investing -37.78
Cash from Financing 37.67
Net change in Cash -0.03
Free Cash Flow 0.13
Particulars MAR 2023 (Values in Cr)
Net Income 0.00
Cash from Operations -0.14
Cash from Investing 0.00
Cash from Financing 0.16
Net change in Cash 0.02
Free Cash Flow -0.14
Particulars MAR 2022 (Values in Cr)
Net Income -0.19
Cash from Operations -0.17
Cash from Investing 0.00
Cash from Financing 0.14
Net change in Cash -0.02
Free Cash Flow -0.17
Particulars MAR 2021 (Values in Cr)
Net Income -0.03
Cash from Operations -0.05
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash -0.05
Free Cash Flow -0.05
Particulars MAR 2020 (Values in Cr)
Net Income -0.04
Cash from Operations 0.02
Cash from Investing 0.00
Cash from Financing 0.00
Net change in Cash 0.01
Free Cash Flow 0.02
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 738.20 39.06 5.59 25910.82 610.50 / 1035.70
KOTHARI INDUSTRIAL CORPORATION 491.35 106.58 25.70 4605.58 9.64 / 501.35
MYSORE PETRO CHEMICALS LTD. 123.45 5.86 0.36 81.27 117.45 / 261.90
OSWAL AGRO MILLS LTD 83.53 9.93 1.17 1121.22 41.69 / 110.69
Company Name Price P/E P/B Market Cap 52 Week Low/High
AEGIS LOGISTICS LIMITED 738.20 48.98 9.26 25910.82 610.50 / 1035.70
UTIQUE ENTERPRISES LIMITED 5.02 55.78 0.39 27.95 3.77 / 8.58
COMPUTER POINT LTD. 5.90 0.00 0.53 17.70 4.24 / 10.96
KOTHARI INDUSTRIAL CORPORATION 491.35 0.00 28.33 4605.58 9.64 / 501.35

FISCHER MEDICAL VENTURES LIMIT Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
845.05 8.91 redarrow
red-green-graph indicator
8 Bearish
8 Bullish
  • 5 Days 810.50
  • 26 Days 810.50
  • 10 Days 810.50
  • 50 Days 810.50
  • 12 Days 810.50
  • 100 Days 810.50
  • 20 Days 810.50
  • 200 Days 810.50
795.28 PIVOT

First Support

750.67

First Resistance

820.47

Second Support

725.48

Second Resistance

865.08

Third Support

680.87

Third Resistance

890.27

RSI

0.00

ADX

100.00

MACD

0.00

Williams % R

-15.69

Commodity Channel Index (CCI)

666.67

Date

2025-07-11

Week

24616.00

Same Day

42561.00

Month

24616.00

1 Year

-64.77

3 Year

-68.97

Over 1 Month

0.00%

down

Over 1 Year

0.00%

down

Over 3 Months

0.00%

down

Over 3 Years

0.00%

down

Over 6 Months

0.00%

down

Over 5 Years

0.00%

down

FISCHER MEDICAL VENTURES LIMIT shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
31.22%
Promoter Holdings
61.79%
FII
5.55%
DII
1.42%
Promoter Shares(Pledge Percentage)
0.0%
Name Shares Category
Time Medical International Ventures Pte Ltd 3.3176112E7 (51.16%) Shareholding of Promoter and Promoter Group
Shankar Varadharajan-preferential Allotm 6900153.0 (10.64%) Shareholding of Promoter and Promoter Group
Roopal Hitesh Kawa 1800029.0 (2.78%) Public Shareholding
Vikasa India Eif I Fund 1665000.0 (2.57%) Public Shareholding
India Emerging Giants Fund Limited 1484155.0 (2.29%) Public Shareholding
Vinay Rajendrakumar Nagda 1000000.0 (1.54%) Public Shareholding
Blue Lotus Capital Multi Bagger Fund Ii 921582.0 (1.42%) Public Shareholding
Suriyamoorthy Shanmugavel 854700.0 (1.32%) Public Shareholding
Kaushik Hasmukhlal Gandhi . 830000.0 (1.28%) Public Shareholding
Hitesh Natwarlal Kawa . 799623.0 (1.23%) Public Shareholding
Natwarlal Keshavjibhai Kawa 798832.0 (1.23%) Public Shareholding
Nimesh Sahadeo Singh 743329.0 (1.15%) Public Shareholding
Vritti Hitesh Kawaroopal Hitesh Kawa 0.0 (0.0%) Public Shareholding
Ravindran Govindan 0.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

FISCHER MEDICAL VENTURES LIMIT corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
[-] [-] [-] [-] [-]
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

FISCHER MEDICAL VENTURES LIMIT Share Price

Fischer Medical Ventures Limited is emerging as a leading player in the trading of MRI systems. Headquartered in the Andhra Pradesh MedTech Zone (AMTZ) in Vishakhapatnam, India, Company is pioneering the development of advanced, affordable, and accessible medical diagnostic and imaging technologies, through its wholly owned subsidiary. In partnership with the wholly owned subsidiary, it has established a significant international footprint, operating across multiple continents and key markets. With a network of manufacturing facilities, distribution channels, and service partners, Company provides MRI solutions to healthcare providers worldwide. This global reach demonstrates its commitment to enhancing medical imaging accessibility for patients around the world.

Fischer Medical Ventures Limited was initially incorporated as 'Fischer Chemic Limited' on March 22, 1993 and obtained the Certificate of Commencement of Business. The Company formed an agreement with the Partnership Firm 'M/s. Fischer Inorganics & Aromatics, Chennai to take over the partnership business as a going concern dated 19 January, 1994. The partnership firm was engaged in the processing/Manufacturing of Laboratory Grade Chemicals. Now, the name of the Company has changed to Fischer Medical Ventures Limited on March 29, 2024.

The Company was incorporated primarily to be engaged in the business of manufacturing of Chemicals. Pursuant to the change in Objects of the Company, there has been change in Nature of Business to developing and trading of Medical Equipment including
the cutting edge Magnetic Resonance Imaging (MRI) systems in India.

The Company has acquired a leading innovator in radiology equipment including Mobile X-Ray Machines, Fixed X-Ray Machines, Computed Radiography Systems, and Digital Radiography Systems in FY 2024. It also acquired a firm specialising in providing IT and digital solutions, offering services such as IT consulting, software development, data analytics, and digital transformation. Further, it acquired a company that has revolutionised the animal vaccination industry with its ground-breaking delivery methods in FY24.

Time Medical International Ventures (India) Private Limited was incorporated a subsidiary of the Company on January 25, 2024.

Parent organization Indian Private
NSE symbol FISCHER
Founded 1993
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Current Share Price of Fischer Medical Ventures Ltd?

Answer Field

Fischer Medical Ventures Ltd share price is for NSE ₹ 845.05 & for BSE ₹ 849.65 as on Jul 11 2025 03:29 PM.

What is the Market Cap of Fischer Medical Ventures Ltd Share?

Answer Field

The market cap of Fischer Medical Ventures Ltd for NSE ₹ 4,521.01 & for BSE ₹ 4,545.62 as on Jul 11 2025 03:29 PM.

What is the 52 Week High and Low of Fischer Medical Ventures Ltd?

Answer Field

The 52 Week High and Low of Fischer Medical Ventures Ltd for NSE is ₹ 859.00 and ₹ 770.10 and for BSE is ₹ 919.00 and ₹ 573.60.

What is 1 year return for Fischer Medical Ventures Ltd?

Answer Field

The 1 year returns on the stock has been 0.00%.

What is the P/E Ratio of Fischer Medical Ventures Ltd Share?

Answer Field

As on Jul 11 2025 03:29 PM the price-to-earnings (PE) ratio for Fischer Medical Ventures Ltd share is 8430.50.

What is the PB ratio of Fischer Medical Ventures Ltd Share?

Answer Field

As on Jul 11 2025 03:29 PM, the price-to-book (PB) ratio for Fischer Medical Ventures Ltd share is 47.63.

How to Buy Fischer Medical Ventures Ltd Share?

Answer Field

You can trade in Fischer Medical Ventures Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Fischer Medical Ventures Ltd Share on Bajaj Broking App?

Answer Field

To buy Fischer Medical Ventures Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Fischer Medical Ventures Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|